BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14670612)

  • 1. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis.
    Semczuk A; Jakowicki JA
    Cancer Lett; 2004 Jan; 203(1):1-12. PubMed ID: 14670612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A; Miturski R; Skomra D; Jakowicki JA
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas.
    Kim H; Ham EK; Kim YI; Chi JG; Lee HS; Park SH; Jung YM; Myung NK; Lee MJ; Jang JJ
    Cancer Lett; 1998 Sep; 131(2):177-83. PubMed ID: 9851251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of exogenous p16 expression on CDK4, Cyclin D1 and pRb in nasopharyngeal carcinoma cell lines].
    Zhao XR; Deng L; Weng XX
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):428-30. PubMed ID: 12212108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicoprognostic significance of pRb1 pathway alterations in uterine endometrial adenocarcinoma.
    Semczuk A; Cybulski M; Tomaszewski J; Rechberger T; Jakowicki JA
    Cancer Genet Cytogenet; 2004 Oct; 154(2):186-9. PubMed ID: 15474160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
    Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
    Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
    Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
    Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb.
    Grønbaek K; Nedergaard T; Andersen MK; thor Straten P; Guldberg P; Møller P; Zeuthen J; Ebbe Hansen N; Hou-Jensen K; Ralfkiaer E
    Leukemia; 1998 Aug; 12(8):1266-71. PubMed ID: 9697882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
    Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
    Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of thymidylate synthase, p16(INK4a), cyclin-dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: significance of p16(INK4a)-mediated cellular arrest as an indicator of chemosensitivity to 5-fluorouracil.
    Kamoshida S; Matsuoka H; Shiogama K; Matsuyama A; Shimomura R; Inada K; Maruta M; Tsutsumi Y
    Pathol Int; 2004 Aug; 54(8):564-75. PubMed ID: 15260847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.